H.B. Fuller (NYSE:FUL – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 4.100-4.200 for the period, compared to the consensus earnings per share estimate of 4.370. The company issued revenue guidance of $3.6 billion-$3.6 billion, compared to the consensus revenue estimate of $3.6 billion. H.B. Fuller also updated its FY24 guidance to $4.10-4.20 EPS.
H.B. Fuller Price Performance
NYSE FUL opened at $80.86 on Friday. The company has a 50-day moving average price of $81.73 and a 200-day moving average price of $79.59. H.B. Fuller has a 52 week low of $64.64 and a 52 week high of $87.67. The company has a quick ratio of 1.16, a current ratio of 1.89 and a debt-to-equity ratio of 1.13. The firm has a market capitalization of $4.41 billion, a P/E ratio of 27.60, a PEG ratio of 1.32 and a beta of 1.42.
H.B. Fuller (NYSE:FUL – Get Free Report) last announced its earnings results on Wednesday, September 25th. The specialty chemicals company reported $1.13 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.10). The business had revenue of $917.93 million for the quarter, compared to analysts’ expectations of $944.04 million. H.B. Fuller had a net margin of 4.67% and a return on equity of 13.33%. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.06 earnings per share. Equities research analysts anticipate that H.B. Fuller will post 4.4 earnings per share for the current year.
H.B. Fuller Increases Dividend
Analysts Set New Price Targets
Separately, StockNews.com downgraded H.B. Fuller from a buy rating to a hold rating in a research note on Wednesday, September 18th.
Insider Activity
In other news, VP Heather Campe sold 23,696 shares of the business’s stock in a transaction dated Friday, July 12th. The stock was sold at an average price of $82.66, for a total value of $1,958,711.36. Following the transaction, the vice president now directly owns 19,742 shares in the company, valued at $1,631,873.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.96% of the company’s stock.
H.B. Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Featured Stories
- Five stocks we like better than H.B. Fuller
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- AI Boom and Rate Cuts Boost Utility Stocks: Best Growth Picks
- Stock Analyst Ratings and Canadian Analyst Ratings
- Top 3 Homebuilder Stocks to Watch as Rates Drop
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.